Corcept Other Current Assets from 2010 to 2025

CORT Stock  USD 55.31  0.87  1.60%   
Corcept Therapeutics Other Current Assets yearly trend continues to be comparatively stable with very little volatility. Other Current Assets are likely to outpace its year average in 2025. Other Current Assets is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. View All Fundamentals
 
Other Current Assets  
First Reported
2000-12-31
Previous Quarter
25.5 M
Current Value
18.7 M
Quarterly Volatility
9.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Corcept Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Corcept Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 4.3 M, Selling General Administrative of 193.1 M or Research Development of 222.6 M, as well as many indicators such as Price To Sales Ratio of 7.62, Dividend Yield of 0.0 or PTB Ratio of 6.27. Corcept financial statements analysis is a perfect complement when working with Corcept Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Corcept Therapeutics Correlation against competitors.

Latest Corcept Therapeutics' Other Current Assets Growth Pattern

Below is the plot of the Other Current Assets of Corcept Therapeutics Incorporated over the last few years. It is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. Corcept Therapeutics' Other Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Corcept Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Other Current Assets10 Years Trend
Slightly volatile
   Other Current Assets   
       Timeline  

Corcept Other Current Assets Regression Statistics

Arithmetic Mean13,986,776
Geometric Mean3,113,124
Coefficient Of Variation139.28
Mean Deviation16,080,664
Median6,044,000
Standard Deviation19,480,186
Sample Variance379.5T
Range50.2M
R-Value0.84
Mean Square Error121.6T
R-Squared0.70
Significance0.000052
Slope3,425,620
Total Sum of Squares5692.2T

Corcept Other Current Assets History

202550.2 M
202447.8 M
202341.6 M
202245 M
202110.3 M
20206.7 M
2019M

About Corcept Therapeutics Financial Statements

Corcept Therapeutics shareholders use historical fundamental indicators, such as Other Current Assets, to determine how well the company is positioned to perform in the future. Although Corcept Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Corcept Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Corcept Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Current Assets47.8 M50.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Corcept Stock Analysis

When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.